Inogen Price to Sales Ratio 2012-2025 | INGN
Historical PS ratio values for Inogen (INGN) over the last 10 years. The current P/S ratio for Inogen as of November 13, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Inogen P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-11-13 | 6.88 | 0.50 | |
| 2025-06-30 | 7.03 | $13.82 | 0.51 |
| 2025-03-31 | 7.13 | $14.15 | 0.50 |
| 2024-12-31 | 9.17 | $14.22 | 0.64 |
| 2024-09-30 | 9.70 | $14.11 | 0.69 |
| 2024-06-30 | 8.13 | $13.98 | 0.58 |
| 2024-03-31 | 8.07 | $13.84 | 0.58 |
| 2023-12-31 | 5.49 | $13.64 | 0.40 |
| 2023-09-30 | 5.22 | $14.22 | 0.37 |
| 2023-06-30 | 11.55 | $15.21 | 0.76 |
| 2023-03-31 | 12.48 | $16.12 | 0.77 |
| 2022-12-31 | 19.71 | $16.52 | 1.19 |
| 2022-09-30 | 24.28 | $16.06 | 1.51 |
| 2022-06-30 | 24.18 | $15.53 | 1.56 |
| 2022-03-31 | 32.42 | $15.44 | 2.10 |
| 2021-12-31 | 34.00 | $15.83 | 2.15 |
| 2021-09-30 | 43.09 | $15.80 | 2.73 |
| 2021-06-30 | 65.17 | $15.10 | 4.31 |
| 2021-03-31 | 52.52 | $13.89 | 3.78 |
| 2020-12-31 | 44.68 | $14.01 | 3.19 |
| 2020-09-30 | 29.00 | $14.19 | 2.04 |
| 2020-06-30 | 35.52 | $14.95 | 2.38 |
| 2020-03-31 | 51.66 | $16.24 | 3.18 |
| 2019-12-31 | 68.33 | $16.21 | 4.22 |
| 2019-09-30 | 47.91 | $16.50 | 2.90 |
| 2019-06-30 | 66.76 | $16.57 | 4.03 |
| 2019-03-31 | 95.37 | $16.37 | 5.83 |
| 2018-12-31 | 124.17 | $15.92 | 7.80 |
| 2018-09-30 | 244.12 | $14.98 | 16.29 |
| 2018-06-30 | 186.33 | $13.92 | 13.39 |
| 2018-03-31 | 122.84 | $12.53 | 9.80 |
| 2017-12-31 | 119.08 | $11.42 | 10.43 |
| 2017-09-30 | 95.10 | $10.92 | 8.71 |
| 2017-06-30 | 95.42 | $10.35 | 9.22 |
| 2017-03-31 | 77.56 | $10.01 | 7.75 |
| 2016-12-31 | 67.17 | $9.64 | 6.97 |
| 2016-09-30 | 59.90 | $9.18 | 6.52 |
| 2016-06-30 | 50.11 | $8.58 | 5.84 |
| 2016-03-31 | 44.98 | $8.11 | 5.55 |
| 2015-12-31 | 40.09 | $7.69 | 5.22 |
| 2015-09-30 | 48.55 | $7.35 | 6.61 |
| 2015-06-30 | 44.60 | $6.84 | 6.52 |
| 2015-03-31 | 31.99 | $6.22 | 5.14 |
| 2014-12-31 | 31.37 | $7.08 | 4.43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.192B | $0.336B |
| Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.924B | 26.25 |
| Intuitive Surgical (ISRG) | United States | $205.210B | 80.29 |
| IDEXX Laboratories (IDXX) | United States | $56.979B | 56.59 |
| Edwards Lifesciences (EW) | United States | $49.662B | 33.30 |
| Alcon (ALC) | Switzerland | $39.183B | 26.48 |
| IQVIA Holdings (IQV) | United States | $37.616B | 20.98 |
| Mettler-Toledo (MTD) | United States | $29.577B | 34.60 |
| STERIS (STE) | Ireland | $26.302B | 27.15 |
| DexCom (DXCM) | United States | $23.249B | 32.05 |
| Waters (WAT) | United States | $23.062B | 30.50 |
| Hologic (HOLX) | United States | $16.584B | 17.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.430B | 0.00 |
| Globus Medical (GMED) | United States | $11.441B | 23.80 |
| Penumbra (PEN) | United States | $10.977B | 77.21 |
| Masimo (MASI) | United States | $8.046B | 25.78 |
| Sysmex ADR (SSMXY) | Japan | $6.553B | 20.82 |
| Glaukos (GKOS) | United States | $5.319B | 0.00 |
| Teleflex (TFX) | United States | $4.927B | 7.85 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.344B | 38.11 |
| LivaNova (LIVN) | United Kingdom | $3.092B | 16.70 |
| Alphatec Holdings (ATEC) | United States | $3.082B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.436B | 11.43 |
| Artivion (AORT) | United States | $2.256B | 103.54 |
| Nihon Kohden (NHNKY) | Japan | $1.858B | 16.22 |
| Elekta AB (EKTAY) | Sweden | $1.739B | 16.85 |
| PROCEPT BioRobotics (PRCT) | United States | $1.719B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.240B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.225B | 0.00 |
| AxoGen (AXGN) | United States | $1.111B | 0.00 |
| IRadimed (IRMD) | United States | $1.099B | 52.38 |
| Pulse Biosciences (PLSE) | United States | $1.017B | 0.00 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.942B | 5.10 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.549B | 31.93 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.546B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.525B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.522B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.475B | 0.00 |
| NeuroPace (NPCE) | United States | $0.450B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.441B | 12.18 |
| OrthoPediatrics (KIDS) | United States | $0.426B | 0.00 |
| RxSight (RXST) | United States | $0.412B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.408B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.390B | 2.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.337B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.303B | 50.53 |
| Spectral Diagnostics (EDTXF) | Canada | $0.298B | 0.00 |
| CVRx (CVRX) | United States | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.212B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.148B | 0.00 |
| Neuronetics (STIM) | United States | $0.148B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| LENSAR (LNSR) | United States | $0.124B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.51 |